ERBB2 and breast carcinoma: In contrast to YKL-39, high epithelial and stromal PD-L1 expression in biopsies obtained before NAC (PTX-based or platinum-based) correlated with increased rate of pCR after NAC, especially in hormone-positive and Her2-postive breast cancer (99).